Fineotex Chemical Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
FCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fineotex Chemical reported consolidated total income of Rs. 19,046 lakhs for Q3 FY26, up 30.96% quarter-on-quarter and 45.49% year-on-year. Profit after tax rose 15.50% Q-o-Q to Rs. 3,012 lakhs but only 8.23% YoY, while operational EBITDA grew 12.28% Q-o-Q to Rs. 3,484 lakhs, indicating margin compression as revenue outpaced profit growth. Consolidated volume grew approximately 39% YoY, and ROIC stood at 26.82%. During the quarter, the company completed the acquisition of US-based specialty chemical group CrudeChem Technologies (CCT Group) through a step-down subsidiary, marking entry into oilfield chemicals. Promoters exercised 5 lakh warrants, with Rs. 35.68 crores received from 75% warrant conversion. The statutory auditor (ASL & Co.) issued an unqualified limited review report.
Strong top-line growth driven by acquisition and volume expansion is positive for shareholders, but the gap between revenue growth (~46% YoY) and profit growth (~8% YoY) suggests margin pressure that could weigh on near-term stock sentiment. The US acquisition and promoter warrant conversion signal strategic expansion and insider confidence.